UPL, FMC Corp Collaborate For Rynaxypyr Active Ingredient: Motilal Oswal Review
BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
Motilal Oswal Report
UPL Ltd. has announced a long-term strategic collaboration with FMC Corporation, a leading global agricultural sciences company.
The pact allows UPL access to key markets prior to the patent expiry and to commercialize Rynaxypyr Active: FMC's leading insecticide.
As per the agreement, UPL will toll manufacture and supply Rynaxypyr to FMC in India. FMC will supply the active ingredient (AI) to UPL depending on the market.
The deal adds a key portfolio of products to company's business and supports FMC in maximizing the penetration of this important AI.
Early access to Rynaxypyr formulations in key markets allows the company to provide farmers with more sustainable product choices.
Click on the attachment to read the full report:
This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.